BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21082931)

  • 1. Clofarabine in leukemia.
    Ghanem H; Jabbour E; Faderl S; Ghandhi V; Plunkett W; Kantarjian H
    Expert Rev Hematol; 2010 Feb; 3(1):15-22. PubMed ID: 21082931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of clofarabine in acute myeloid leukemia.
    Ghanem H; Kantarjian H; Ohanian M; Jabbour E
    Leuk Lymphoma; 2013 Apr; 54(4):688-98. PubMed ID: 22957815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.
    Faderl S; Gandhi V; Keating MJ; Jeha S; Plunkett W; Kantarjian HM
    Cancer; 2005 May; 103(10):1985-95. PubMed ID: 15803490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.
    Kline JP; Larson RA
    Expert Opin Pharmacother; 2005 Dec; 6(15):2711-8. PubMed ID: 16316309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
    Lech-Maranda E; Korycka A; Robak T
    Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofarabine in the treatment of myelodysplastic syndromes.
    Bryan J; Kantarjian H; Prescott H; Jabbour E
    Expert Opin Investig Drugs; 2014 Feb; 23(2):255-63. PubMed ID: 24410313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clofarabine: a new treatment option for patients with acute myeloid leukemia.
    Larson ML; Venugopal P
    Expert Opin Pharmacother; 2009 Jun; 10(8):1353-7. PubMed ID: 19463072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofarabine: emerging role in leukemias.
    Sampat K; Kantarjian H; Borthakur G
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1559-64. PubMed ID: 19715446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of anti-cancer action and pharmacology of clofarabine.
    Zhenchuk A; Lotfi K; Juliusson G; Albertioni F
    Biochem Pharmacol; 2009 Dec; 78(11):1351-9. PubMed ID: 19576186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofarabine (2-chloro-2'-fluoro-2'-deoxyarabinosyladenine)--biochemical aspects of anticancer activity.
    Majda K; Lubecka K; Kaufman-Szymczyk A; Fabianowska-Majewska K
    Acta Pol Pharm; 2011; 68(4):459-66. PubMed ID: 21796927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofarabine in pediatric acute leukemia: current findings and issues.
    Hijiya N; Barry E; Arceci RJ
    Pediatr Blood Cancer; 2012 Sep; 59(3):417-22. PubMed ID: 22354543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofarabine.
    Drugs R D; 2004; 5(4):213-7. PubMed ID: 15230627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.
    Tran H; Yang D
    Ann Pharmacother; 2012 Jan; 46(1):89-96. PubMed ID: 22170975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofarabine for myelodysplastic syndromes.
    Tiu RV; Traina F; Sekeres MA
    Expert Opin Investig Drugs; 2011 Jul; 20(7):1005-14. PubMed ID: 21591997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias.
    Faderl S; Gandhi V; O'Brien S; Bonate P; Cortes J; Estey E; Beran M; Wierda W; Garcia-Manero G; Ferrajoli A; Estrov Z; Giles FJ; Du M; Kwari M; Keating M; Plunkett W; Kantarjian H
    Blood; 2005 Feb; 105(3):940-7. PubMed ID: 15486072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofarabine: past, present, and future.
    Kantarjian HM; Jeha S; Gandhi V; Wess M; Faderl S
    Leuk Lymphoma; 2007 Oct; 48(10):1922-30. PubMed ID: 17852710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clofarabine and nelarabine: two new purine nucleoside analogs.
    Gandhi V; Plunkett W
    Curr Opin Oncol; 2006 Nov; 18(6):584-90. PubMed ID: 16988579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel purine nucleoside analogues for hematological malignancies.
    Korycka A; Lech-MaraƄda E; Robak T
    Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):123-36. PubMed ID: 18537755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management with clofarabine for refractory leukaemia in a young adult with chronic renal failure.
    Sudour H; Kimmoun A; Contet A; Clement L; Salmon A; Schmitt C; Chastagner P
    Am J Hematol; 2011 Mar; 86(3):321-3. PubMed ID: 21328440
    [No Abstract]   [Full Text] [Related]  

  • 20. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
    Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.